Birchview Capital as of March 31, 2026
Portfolio Holdings for Birchview Capital
Birchview Capital holds 73 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Kla Corporation Com New (KLAC) | 16.7 | $29M | 20k | 1472.41 | |
| Bristol Myers Squibb (BMY) | 10.6 | $19M | 306k | 60.65 | |
| Compass Therapeutics (CMPX) | 4.4 | $7.8M | 1.5M | 5.29 | |
| Lam Research Corporation Com New (LRCX) | 4.4 | $7.7M | 36k | 213.66 | |
| Stoke Therapeutics (STOK) | 3.9 | $6.8M | 210k | 32.56 | |
| Encana Corporation (OVV) | 3.6 | $6.4M | 108k | 59.36 | |
| Intellia Therapeutics (NTLA) | 3.3 | $5.7M | 445k | 12.82 | |
| Structure Therapeutics Spons Adr (GPCR) | 2.7 | $4.8M | 100k | 48.20 | |
| Solid Biosciences Com New (SLDB) | 2.6 | $4.5M | 626k | 7.20 | |
| Prothena Corp SHS (PRTA) | 2.5 | $4.4M | 449k | 9.72 | |
| Biodesix | 2.4 | $4.2M | 287k | 14.50 | |
| ACADIA Pharmaceuticals (ACAD) | 2.2 | $3.8M | 171k | 22.26 | |
| Protagonist Therapeutics (PTGX) | 2.1 | $3.7M | 35k | 105.40 | |
| Neurocrine Biosciences (NBIX) | 2.0 | $3.6M | 27k | 131.74 | |
| Olema Pharmaceuticals (OLMA) | 1.9 | $3.3M | 219k | 14.91 | |
| Relmada Therapeutics (RLMD) | 1.6 | $2.8M | 409k | 6.96 | |
| Ocular Therapeutix (OCUL) | 1.5 | $2.7M | 320k | 8.47 | |
| United Therapeutics Corporation (UTHR) | 1.5 | $2.7M | 4.5k | 592.98 | |
| Nektar Therapeutics (NKTR) | 1.3 | $2.2M | 31k | 71.95 | |
| Celldex Therapeutics Com New (CLDX) | 1.3 | $2.2M | 70k | 31.72 | |
| Novocure Ord Shs (NVCR) | 1.3 | $2.2M | 202k | 10.90 | |
| EQT Corporation (EQT) | 1.3 | $2.2M | 35k | 63.64 | |
| Phathom Pharmaceuticals (PHAT) | 1.2 | $2.2M | 195k | 11.11 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 1.2 | $2.2M | 464k | 4.64 | |
| Compass Pathways Sponsored Ads (CMPS) | 1.2 | $2.1M | 375k | 5.53 | |
| Pacific Biosciences of California (PACB) | 1.1 | $2.0M | 1.5M | 1.32 | |
| Cytokinetics (CYTK) | 1.1 | $2.0M | 30k | 65.91 | |
| Corcept Therapeutics Incorporated (CORT) | 1.1 | $1.9M | 47k | 40.31 | |
| Vera Therapeutics Cl A (VERA) | 1.0 | $1.8M | 44k | 40.23 | |
| Alkermes SHS (ALKS) | 1.0 | $1.8M | 50k | 35.36 | |
| Engene Holdings (ENGN) | 1.0 | $1.7M | 250k | 6.81 | |
| Uniqure Nv SHS (QURE) | 0.9 | $1.6M | 101k | 16.35 | |
| Zenas Biopharma (ZBIO) | 0.8 | $1.4M | 70k | 19.55 | |
| Quidel Corporation | 0.8 | $1.4M | 83k | 16.43 | |
| Foghorn Therapeutics (FHTX) | 0.8 | $1.3M | 282k | 4.78 | |
| Ultragenyx Pharmaceutical (RARE) | 0.7 | $1.3M | 62k | 20.95 | |
| Xenon Pharmaceuticals (XENE) | 0.7 | $1.2M | 21k | 58.15 | |
| Kalvista Pharmaceuticals (KALV) | 0.7 | $1.1M | 57k | 20.13 | |
| Immunome (IMNM) | 0.6 | $1.1M | 50k | 21.87 | |
| Freeport-mcmoran Cl-b CL-B (FCX) | 0.6 | $1.1M | 18k | 58.78 | |
| Axsome Therapeutics (AXSM) | 0.6 | $1.0M | 6.0k | 169.02 | |
| Biogen Idec (BIIB) | 0.5 | $917k | 5.0k | 183.33 | |
| Lipocine Com New (LPCN) | 0.5 | $893k | 112k | 7.99 | |
| Travere Therapeutics (TVTX) | 0.5 | $868k | 29k | 29.71 | |
| Harrow Health (HROW) | 0.5 | $846k | 24k | 35.26 | |
| Pharvaris N V (PHVS) | 0.5 | $843k | 30k | 28.25 | |
| Verastem Com New (VSTM) | 0.5 | $795k | 150k | 5.30 | |
| Apogee Therapeutics (APGE) | 0.4 | $758k | 9.0k | 84.17 | |
| Halozyme Therapeutics (HALO) | 0.4 | $653k | 10k | 64.63 | |
| Bridgebio Pharma (BBIO) | 0.4 | $645k | 8.7k | 74.26 | |
| Apellis Pharmaceuticals (APLS) | 0.3 | $563k | 14k | 40.23 | |
| Ideaya Biosciences (IDYA) | 0.3 | $562k | 17k | 33.32 | |
| Arcus Biosciences Incorporated (RCUS) | 0.3 | $559k | 26k | 21.60 | |
| Regenxbio Inc equity us cm (RGNX) | 0.3 | $555k | 66k | 8.38 | |
| Karyopharm Therapeutics | 0.3 | $468k | 84k | 5.57 | |
| Rocket Pharmaceuticals (RCKT) | 0.3 | $455k | 127k | 3.58 | |
| Miragen Therapeutics (VRDN) | 0.2 | $393k | 20k | 19.56 | |
| Outset Med | 0.2 | $380k | 99k | 3.84 | |
| Pulmonx Corp (LUNG) | 0.2 | $323k | 250k | 1.29 | |
| Castle Biosciences (CSTL) | 0.2 | $317k | 13k | 24.55 | |
| Trinity Cap (TRIN) | 0.2 | $294k | 20k | 14.71 | |
| Candel Therapeutics (CADL) | 0.2 | $294k | 60k | 4.90 | |
| Voyager Therapeutics (VYGR) | 0.2 | $289k | 75k | 3.86 | |
| Cullinan Oncology (CGEM) | 0.2 | $284k | 20k | 14.21 | |
| Kayne Anderson Bdc Com Shs (KBDC) | 0.2 | $274k | 20k | 13.72 | |
| Acasti Pharma (GRCE) | 0.1 | $232k | 50k | 4.63 | |
| Aziyo Biologics (ELUT) | 0.1 | $173k | 165k | 1.05 | |
| Kyntra Bio Com New (KYNB) | 0.1 | $153k | 23k | 6.78 | |
| Quoin Pharmaceuticals Sponsored Ads (QNRX) | 0.1 | $132k | 20k | 6.60 | |
| Phreesia (PHR) | 0.1 | $120k | 14k | 8.38 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.0 | $41k | 18k | 2.34 | |
| Docgo (DCGO) | 0.0 | $25k | 40k | 0.63 | |
| Gossamer Bio (GOSS) | 0.0 | $6.0k | 18k | 0.33 |